The FINANCIAL -- Pfizer Inc. and Eli Lilly and Company announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary ...

The FINANCIAL -- The number of cancer cases is growing, and while the effectiveness of treatments is increasing, it is important not to overlook the side effects of these therapies, some of which ...

The FINANCIAL -- The first major paper looking at the causes and consequences of meningitis in the UK has found that viruses are now the most common cause of meningitis in adults and a cause of ...

The FINANCIAL -- Geneva, 17th July 2018 – Eni and IRCCS Giannina Gaslini, one of Europe’s most important paediatric hospitals, have agreed a partnership to implement paediatric initiatives, ...

The FIANCIAL -- The University has secured £2 million from the National Institute for Health Research (NIHR) to improve the management of devastating brain infections in low and middle income ...